Ligand validation:3WLI

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3WLI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WLI_NAG_A_701	43%	55%	0.147	0.87	0.77	0.96	-	-	0	0	100%	0.9333
3WLI_NAG_A_703	31%	61%	0.198	0.867	0.42	1.07	-	-	0	0	100%	0.9333
3WLI_NAG_A_702	2%	40%	0.314	0.623	0.66	1.63	-	4	0	0	100%	0.9333
6MD6_NAG_A_701	55%	35%	0.137	0.906	0.86	1.69	-	5	1	0	100%	0.9333
6JGL_NAG_A_703	55%	25%	0.156	0.923	1.07	1.93	1	7	0	0	100%	0.9333
3WLR_NAG_A_703	53%	15%	0.14	0.901	1	2.69	1	8	0	0	100%	0.9333
6JGC_NAG_A_703	46%	35%	0.18	0.917	0.79	1.73	-	2	1	0	100%	0.9333
6JGO_NAG_A_701	44%	40%	0.198	0.926	0.75	1.57	-	4	1	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.